OPUS Study: Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (BY217/M2-111)
Completed · Phase 3
Conditions studied: Chronic Obstructive Pulmonary Disease, COPD
In brief
The purpose of this study is to determine whether roflumilast is effective in the treatment of exacerbations in patients with chronic obstructive pulmonary disease (COPD).
Key facts
- Study ID
- NCT00076089
- Run by
- AstraZeneca
- People needed
- 1100
- Starts
- 2003-12-01
- Expected to finish
- 2005-12-01
- Last updated by the study team
- 2016-12-02
Who can join
Age: 40 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- ALTANA Pharma — Cities in Alabama, Alabama, United States
- ALTANA Pharma — Cities in Arizona, Arizona, United States
- ALTANA Pharma — Cities in Arkansas, Arkansas, United States
- ALTANA Pharma — Cities in California, California, United States
- ALTANA Pharma — Cities in Colorado, Colorado, United States
- ALTANA Pharma — Cities in Connecticut, Connecticut, United States
- ALTANA Pharma — Cities in Florida, Florida, United States
- ALTANA Pharma — Cities in Georgia, Georgia, United States
- ALTANA Pharma — Cities in Illionois, Illinois, United States
- ALTANA Pharma — Cities in Iowa, Iowa, United States
- ALTANA Pharma — Cities in Kentucky, Kentucky, United States
- ALTANA Pharma — Cities in Louisiana, Louisiana, United States
- ALTANA Pharma — Cities in Massachusetts, Massachusetts, United States
- ALTANA Pharma — Cities in Minnesota, Minnesota, United States
- ALTANA Pharma — Cities in Missouri, Missouri, United States
- ALTANA Pharma — Cities in Montana, Montana, United States
- ALTANA Pharma — Cities in Nebraska, Nebraska, United States
- ALTANA Pharma — Cities in Nevada, Nevada, United States
- ALTANA Pharma — Cities in New Hampshire, New Hampshire, United States
- ALTANA Pharma — Cities in New Jersey, New Jersey, United States
- ALTANA Pharma — Cities in New York, New York, United States
- ALTANA Pharma — Cities in North Carolina, North Carolina, United States
- ALTANA Pharma — Cities in Ohio, Ohio, United States
- ALTANA Pharma — Cities in Oklahoma, Oklahoma, United States
- ALTANA Pharma — Cities in Oregon, Oregon, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.